Telix Pharmaceuticals Limited (TLPPF) Operating income 2023–2025
Telix Pharmaceuticals Limited (TLPPF) annual operating income history from SEC filings — each fiscal year as reported.
$29.8MFY2025 · since FY2023: $11.0M → $29.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.8M | -46.0% |
| FY2024 | $55.2M | +401.2% |
| FY2023 | $11.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TLPPF financial trends
TLPPF RevenueTLPPF Net incomeTLPPF Net marginTLPPF Gross profitTLPPF Gross marginTLPPF Operating marginTLPPF Operating cash flowTLPPF Free cash flowTLPPF Capital expendituresTLPPF Return on equityTLPPF Stock buybacksTLPPF Dividends paidTLPPF Total assetsTLPPF Total liabilitiesTLPPF Shareholders’ equityTLPPF overview →